New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Vext Science, Inc.
VEXTF
Shape
US Flag

PNK

EPS improving

EPS improving

34M

Drug Manufacturers - Specialty & Generic

Next Earning date - 26 Nov 2024

34M

Drug Manufacturers - Specialty & Generic

Next Earning date - 26 Nov 2024

0.14USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-28%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

57%

Quote Panel

Shape
Updated October 26, 2024
1W -8.61 % 1M -23.84 % 3M -21.60 % 1Y -35.73 %

Key Metrics

Shape
  • Market Cap

    33.68M


  • Shares Outstanding

    245.67M


  • Share in Float

    245.67M


  • Dividende

    0


  • Earning Date

    26 Nov 2024


  • Price Target

    0.13708


  • Average Volume

    26678


  • Beta

    1.725


  • Range

    0.13-0.3181


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.vextscience.com


  • Sector

    Healthcare


Fundamentals

Shape

14.49x

P/E Ratio

1.00x

P/S Ratio

0.39x

P/B Ratio

0.4

Debt/Equity

-20.6%

Net Margin

$0.0

EPS

How VEXTF compares to sector?

P/E Ratio

Relative Strength

Shape

VEXTF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$58M

Shape587%

2025-Revenue

$0.02

Shape-6%

2025-EPS

$13M

Shape1607%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+351%

0.05
vs 0.01

Q4.22

arrow
arrow

N/A

0
vs NA

Q1.23

arrow
arrow

N/A

NA
vs 0.01

Q2.23

arrow
arrow

N/A

-0.01
vs 0.02

Q3.23

arrow
arrow

-17%

0.04
vs 0.05

Q4.23

arrow
arrow

N/A

NA
vs 0

Q1.24

arrow
arrow

N/A

-0.03
vs NA

Q2.24

arrow
arrow

+100%

NA
vs -0.01

Q3.24

arrow
arrow

N/A

-0.01
vs 0.04

Q4.24

arrow
arrow

N/A

-0.01
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-18%

7.7M  vs 9.4M

Q4.22

arrow
arrow

-12%

8.2M  vs 9.3M

Q1.23

arrow
arrow

-16%

9.1M  vs 10.8M

Q2.23

arrow
arrow

+5%

9.2M  vs 8.8M

Q3.23

arrow
arrow

+6%

8.1M  vs 7.7M

Q4.23

arrow
arrow

+6%

8.6M  vs 8.2M

Q1.24

arrow
arrow

-8%

8.4M  vs 9.1M

Q2.24

arrow
arrow

-8%

8.4M  vs 9.2M

Q3.24

arrow
arrow

+16%

9.4M  vs 8.1M

Q4.24

arrow
arrow

+25%

10.8M  vs 8.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+1%

0.01
vs 0.03

Q4.22

arrow
arrow

+9%

0.09
vs 0.01

Q1.23

arrow
arrow

+0%

0
vs 0.09

Q2.23

arrow
arrow

+1%

0.01
vs 0

Q3.23

arrow
arrow

-3%

-0.03
vs 0.01

Q4.23

arrow
arrow

+6%

0.06
vs -0.03

Q1.24

arrow
arrow

-7%

-0.07
vs 0.06

Q2.24

arrow
arrow

-5%

-0.05
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

1

1
vs 1

NA

Q2.21

arrow
arrow

1

1
vs 1

NA

Q3.21

arrow
arrow

1

1
vs 1

NA

Q4.21

arrow
arrow

1

1
vs 1

NA

Q1.22

arrow
arrow

1

1
vs 1

NA

Q2.22

arrow
arrow

1

1
vs 1

NA

Q3.22

arrow
arrow

1

1
vs 1

NA

Q4.22

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News

VEXTF

newsfilecorp.com

17 hours ago